Breath methane excretion in patients with unresected colorectal cancer.
The objective of our study was to verify or refute the observation that patients with unresected colorectal cancer are more likely to be breath methane excretors than the general population. Intracolonic heme had no effect on breath methane excretion of 11 normal volunteers given oral hemoglobin. Laxative-enema colonoscopy preparation had a profound effect on the subsequent measurement of breath methane. Three of 4 volunteer methane excretors became nonexcretors, and 2 remained nonexcretors for 21 days and 7 months, respectively. No significant difference was found in the frequency and the amount of breath methane excretion in 55 patients with unresected colorectal cancer and in 99 control subjects. However, 13 patients with unresected descending or sigmoid colon cancers were almost twice as likely to be breath methane excretors as 38 patients with colorectal cancer at other sites.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001944:Breath Tests; D002400:Cathartics / Q000494:pharmacology; D012809:Colon, Sigmoid; D003110:Colonic Neoplasms / Q000378:metabolism*; D004733:Enema; D005260:Female; D006454:Hemoglobins / Q000494:pharmacology; D006801:Humans; D008297:Male; D008697:Methane / Q000032:analysis*; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000378:metabolism*; D012189:Retrospective Studies
D000900:Anti-Bacterial Agents; D002400:Cathartics; D006454:Hemoglobins; D008697:Methane